Current status of staging laparotomy in colorectal and ovarian cancer.
暂无分享,去创建一个
[1] B. Eisenberg,et al. Is CT portography (CTAP) really useful in patients with liver tumors who undergo intraoperative ultrasonography (IOUS)? , 1995, The American surgeon.
[2] R. McLeod,et al. Reliability and validity studies of endoluminal ultrasonography for anorectal disorders , 1994, Diseases of the colon and rectum.
[3] C. Moertel. Chemotherapy for colorectal cancer. , 1994, The New England journal of medicine.
[4] R. Kane,et al. Intraoperative ultrasound imaging of the liver at the time of colorectal cancer resection. , 1994, Archives of surgery.
[5] L. Herrera,et al. Prognostic profile in rectal cancer , 1994, Diseases of the colon and rectum.
[6] P. Sugarbaker. Intraperitoneal chemotherapy for treatment and prevention of peritoneal carcinomatosis and sarcomatosis , 1994, Diseases of the colon and rectum.
[7] T. Babineau,et al. Role of staging laparoscopy in the treatment of hepatic malignancy. , 1994, American Journal of Surgery.
[8] Hogan Wm,et al. The role of surgery in the management of recurrent gynecologic cancer. , 1993 .
[9] S. Rubin,et al. Second-Look Laparotomy in Stage I Ovarian Cancer Following Comprehensive Surgical Staging , 1993, Obstetrics and gynecology.
[10] K. Podratz,et al. Second-look operation in ovarian cancer. , 1993, Cancer.
[11] U. Herzog,et al. How accurate is endorectal ultrasound in the preoperative staging of rectal cancer? , 1993, Diseases of the colon and rectum.
[12] R. McLeod,et al. Endoluminal transrectal ultrasonography: Accuracy, reliability, and validity , 1993, Diseases of the colon and rectum.
[13] R. Bleday,et al. Recent advances in surgery for colon and rectal cancer. , 1993, Current problems in cancer.
[14] P. Humphrey,et al. Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation. , 1992, Journal of the National Cancer Institute.
[15] G. Steele. Adjuvant therapy for patients with colon and rectal cancer: clinical indications for multimodality therapy in high-risk groups and specific surgical questions for future multimodality trials. , 1992, Surgery.
[16] J. Thigpen,et al. The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study. , 1992, Gynecologic oncology.
[17] A. Berens,et al. Radioimmunoguided surgery challenges traditional decision making in patients with primary colorectal cancer. , 1992, Surgery.
[18] D. Krag,et al. Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: comparison with CT. , 1992, Radiology.
[19] D. Elias,et al. Preoperative assessment of resectability of hepatic metastases from colonic carcinoma: CT portography vs sonography and dynamic CT. , 1992, AJR. American journal of roentgenology.
[20] F. Greene. Laparoscopy in malignant disease. , 1992, The Surgical clinics of North America.
[21] H. Honda,et al. Limitations of current preoperative liver imaging techniques for intrahepatic metastatic nodules of hepatocellular carcinoma , 1992, Hepatology.
[22] G. Gatta,et al. Clinical and pathologic prognostic indicators in colorectal cancer. A population‐based study , 1992 .
[23] Hanks Ge,et al. The role of adjuvant radiation in the treatment of rectal cancer. , 1991 .
[24] D. Krag,et al. Radiolabeled Antibody Imaging in the Management of Colorectal Cancer Results of a Multicenter Clinical Study , 1991, Annals of surgery.
[25] E. Martin,et al. Impact of Radioimmunoguided Surgery. , 1991, Seminars in surgical oncology.
[26] S. Rubin,et al. Intraperitoneal cisplatin and cytarabine in the treatment of refractory or recurrent ovarian carcinoma. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] S. Ellenberg,et al. Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials , 1990, The New England journal of medicine.
[28] J. Wittenberg,et al. Preoperative staging and assessment of resectability of pancreatic cancer. , 1990, Archives of surgery.
[29] S. Horii,et al. Prenatal diagnosis of nephroblastomatosis in two siblings. , 1990, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[30] T. Ravikumar,et al. Prospective comparison of preoperative imaging and intraoperative ultrasonography in the detection of liver tumors , 1989, Surgery.
[31] I. Watt,et al. Laparoscopy, ultrasound and computed tomography in cancer of the oesophagus and gastric cardia: A prospective comparison for detecting intra‐abdominal metastases , 1989, The British journal of surgery.
[32] J. Jenrette,et al. Intraperitoneal P‐32 after negative second‐look laparotomy in ovarian carcinoma , 1989, Cancer.
[33] G. Parker,et al. Intraoperative Ultrasound of the Liver Affects Operative Decision Making , 1989, Annals of surgery.
[34] L. Einhorn,et al. Ten-year follow-up of patients receiving cisplatin, doxorubicin, and cyclophosphamide chemotherapy for advanced epithelial ovarian carcinoma. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] A. Moss,et al. Imaging of colorectal carcinoma. , 1989, Radiology.
[36] P. Choyke,et al. Prospective evaluation of hepatic imaging studies in the detection of colorectal metastases: correlation with surgical findings. , 1989, Surgery.
[37] R. Bast,et al. Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant disease. , 1988, American journal of obstetrics and gynecology.
[38] M. Piver,et al. The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] F. Askin,et al. Intraperitoneal chromic phosphate therapy after second‐look laparotomy for ovarian cancer , 1988, Cancer.
[40] S. Ellenberg,et al. Results of Second‐Look Laparotomy in Patients With Early‐Stage Ovarian Carcinoma , 1987, Obstetrics and gynecology.
[41] B. Gondos,et al. The role of second-look laparotomy in treatment of epithelial ovarian cancer. , 1987, Gynecologic oncology.
[42] F. Kelvin,et al. Colorectal carcinoma: a radiologic and clinical review. , 1987, Radiology.
[43] W. Creasman,et al. Intraperitoneal chromic phosphate P 32 as salvage therapy for persistent carcinoma of the ovary after surgical restaging. , 1987, American journal of obstetrics and gynecology.
[44] J. Emond,et al. Utility of operative ultrasound in the surgical management of liver tumors. , 1986, Annals of surgery.
[45] A. Heintz,et al. Cytoreductive surgery in ovarian carcinoma: Feasibility and morbidity , 1986 .
[46] W. Creasman,et al. Computed tomography in evaluation of patients with ovarian carcinoma in complete clinical remission. Correlation with surgical-pathologic findings. , 1986, JAMA.
[47] G. Malkasian,et al. Second-look laparotomy in ovarian cancer: evaluation of pathologic variables. , 1985, American journal of obstetrics and gynecology.
[48] A. Dembo. Abdominopelvic radiotherapy in ovarian cancer. A 10‐year experience , 1985, Cancer.
[49] H. Norris,et al. Misstaging of Ovarian Cancer , 1985, Obstetrics and gynecology.
[50] B. Edwards,et al. The cyclophosphamide, hexamethylmelamine, 5 fluorouracil (CHF) regimen in the treatment of advanced and recurrent ovarian cancer. , 1985, Gynecologic oncology.
[51] D. Oram,et al. Stage III epithelial ovarian cancer: the role of maximal surgical reduction. , 1984, Gynecologic oncology.
[52] E. Burghardt,et al. The significance of lymphadenectomy in therapy of ovarian carcinoma. , 1983, American journal of obstetrics and gynecology.
[53] R. Elashoff,et al. Primary Cytoreductive Surgery for Epithelial Ovarian Cancer , 1983, Obstetrics and gynecology.
[54] Griffiths Ct. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. , 1975 .
[55] J. Smith,et al. Chemotherapy in advanced ovarian cancer. , 1975, National Cancer Institute monograph.